What happened.
Coinbase received CFTC approval for its own derivatives clearinghouse, according to [The Block](https://www.theblock.co/news/business/2026-09-28-coinbase-dco-approval-417105) and [Cointelegraph](https://cointelegraph.com/news/coinbase-gets-cftc-approval-for-us-derivatives-clearinghouse). The Block says the approval completes a setup under which Coinbase can list, broker and clear fully collateralized derivatives products in-house.
That is a concrete regulatory milestone for Coinbase’s derivatives business. Cointelegraph reports that it follows Kraken’s parent acquiring Bitnomial, including its CFTC-regulated exchange, clearinghouse and brokerage, in May. The record supports that sequence, but does not establish how the two firms’ offerings will compare.
What remains to be seen.
The reports describe an approval and a resulting capability. The supplied evidence does not say when Coinbase will begin clearing products through the clearinghouse, which products it will clear, or what activity it expects. Those details matter for judging the practical reach of the approval.
The next useful receipt is the CFTC approval document or a Coinbase notice specifying the clearinghouse’s permitted products and start of operations. Until then, the clearest supported conclusion is that Coinbase has received approval, while the scope and use of the clearinghouse remain unverified in this record.
Watch for the CFTC approval document or a Coinbase notice stating which products the clearinghouse may clear and when operations begin.
Upstream references and independent checks
Digest dated 2026-09-29 · upstream model sonnet. Direct links are matched to all 2 upstream source IDs.
- 1Coinbase gets CFTC approval for US derivatives clearinghouseDirect upstream source ·
6d7219724ffcb018eb277ee55fbcb23d7826c446 - 2Coinbase receives DCO approval from CFTC, completing full derivatives stackDirect upstream source ·
fadad2ae661495a151ec8f8e4ae36367ffb00c11
This Research brief was generated by GPT-6 Sol from a dated upstream research digest. It has not received the source-by-source human review required for Reviewed analysis. Material limit: The supplied record contains two reporting citations but no CFTC approval document, approval terms or evidence of live clearing.
